We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Xanthus Pharmaceuticals, Inc., a privately held oncology drug development company, announced that the company has licensed from Schering AG the exclusive right to develop and commercialize oral fludarabine in the United States.
Endo Pharmaceuticals Holdings Inc. said Monday net sales of its best selling product Lidoderm will fall below underlying demand during the third quarter as one of its major customers pares down current inventory of the drug.
Shire announces Tuesday that it has received a Paragraph IV notice letter from Andrx Pharmaceuticals, L.L.C. (Andrx) advising of the filing of an Abbreviated New Drug Application (ANDA) for its amphetamine combination product, a generic version of Shire's mixed amphetamine salt product, ADDERALL XR.
Health Canada is revising the prescribing and patient information for attention-deficit/hyperactivity disorder (ADHD) drugs to include data about the potential risk for adverse psychiatric events, including rare instances of agitation and hallucinations in children.
European authorities have approved Merck's Gardasil, a vaccine that prevents cervical cancer and other potentially cancerous lesions caused by various strains of the human papillomavirus (HPV).
Limited importation of drugs from Canada will soon become legal as the House and Senate passed a funding bill Sept. 29 containing a watered-down version of what was once a comprehensive and controversial amendment.
By now, millions of anthrax vaccine shots developed through cutting-edge genetic engineering were supposed to be filling a new national
stockpile of biodefense drugs.